Human clinical trials are supposed to answer one simple question: does this treatment work, and is it safe? But the first time a new drug is given to a person, known as a first in human study, is where many biotech programs quietly go wrong. The problem is rarely bad luck. It is usually study […]
Most articles on choosing a CRO partner tell you the same thing. Look for experience. Check regulatory expertise. Ask about quality systems. This advice is not necessarily wrong, but it is not very useful either. Almost every CRO company will claim to tick these boxes on their website. The real problem is different. Sponsors usually know what to look for. What they don’t have […]
If your pharma company is planning its first trial, or bringing in a new team to run one, you have probably heard people throw around terms like “Phase II” or “Phase III” in meetings. It can feel like everyone else already knows what this mean, and you are the only one guessing. In this blog, we have broken down clinical […]
Managing a clinical trial means balancing timelines, teams, budgets, data quality, and regulatory requirements at the same time. Effective clinical trial project management brings these moving parts together, helping study teams identify risks early, maintain compliance, and keep trials progressing smoothly from start-up through close-out. Why It Matters and How to Keep Teams, Timelines, and […]
Clinical trials generate large amounts of data. However, collecting data is only one part of the process. The real value comes from analysing that data correctly and drawing reliable conclusions from it. This is where clinical biostatistics services play an important role. Biostatisticians help research teams plan the right analytical approach, reduce bias, check data quality, and apply suitable statistical methods. […]
The demand for clinical trial services is growing fast. According to MarketsandMarkets, the global clinical trial services market was valued at $60.76 billion in 2024 and is expected to reach $101.86 billion by 2030. With so many CROs competing for your business, it is easy to feel overwhelmed during the selection process. An experienced CRO can complete the trail in given time […]
Bringing a new drug to market is a long and expensive journey. According to Pharma, it takes 10 to 15 years and costs over $2.6 billion to develop a single new medicine. And even after all that, many drugs still fail before they reach patients. For pharma companies, biotech firms, and medical device developers, one of the biggest challenges is running […]
A clinical trial rarely fails overnight. It usually begins with small warning signs: a delayed document, an overpromised recruitment number, a site that looked strong during feasibility but underperformed after activation, or safety updates that were not escalated in time. For pharma sponsors, choosing a clinical research organization in India is not just a vendor decision. It […]
Clinical trials succeed or fail on the strength of their data. At Innovate Research, we know that trial efficiency is not merely about speed but about: designing studies that ask the right questions analysing data correctly the first time, and producing results regulators can trust. As clinical research grows more complex, many sponsors are recognising that in-house […]
If you’re planning a clinical trial in India, you’ve probably already heard the pitch: lower costs, a massive patient pool, and a growing regulatory infrastructure. It’s all true. But here’s what doesn’t get talked about enough: Your outsourcing model matters just as much as where you run the trial. Choose the wrong model, and you […]
